Digital Health

FDA Sets New Regulatory Rules for Cardiovascular AI Software
Tech & Innovation FDA Sets New Regulatory Rules for Cardiovascular AI Software

The move to categorize cardiovascular machine learning software under regulation 21 CFR 870.2380 creates a new benchmark for medical technology safety. This initiative by the U.S. Food and Drug Administration clarifies the expectations for how digital tools are developed, validated, and brought to

Cyberattacks Target 60% of Colombian Healthcare Providers
Tech & Innovation Cyberattacks Target 60% of Colombian Healthcare Providers

As the healthcare system becomes more integrated, the increasing number of stakeholders with network access makes maintaining a secure digital perimeter significantly more difficult. Recent data from Biofile, analyzed alongside IBM’s X-Force Index, reveals a disturbing trend where 60% of all

How Does HIPAA Impact Modern Digital Advertising?
Tech & Innovation How Does HIPAA Impact Modern Digital Advertising?

Healthcare advertisers often utilize National Provider Identifier numbers to target clinicians professionally, thereby bypassing the strict patient privacy restrictions tied to protected health information. This strategic shift has become a defining characteristic of the 2026 digital landscape, as

How Can Biosecurity Distinguish Dissent From Misinformation?
Tech & Innovation How Can Biosecurity Distinguish Dissent From Misinformation?

The politicization of daily life during biological emergencies makes the governance of information as critical to safety as the distribution of essential medical supplies. In the contemporary landscape of 2026, the success of any public health intervention is no longer measured solely by laboratory

How Can Ultrasound Detect Botfly Larvae After Travel?
Tech & Innovation How Can Ultrasound Detect Botfly Larvae After Travel?

The detection of rhythmic internal contractions during a real-time ultrasound scan provides a pathognomonic sign that confirms the presence of a living organism. As international travel continues to rise in 2026, medical practitioners in temperate regions are increasingly encountering tropical

Can Biomarkers End Trial and Error in Depression Treatment?
Tech & Innovation Can Biomarkers End Trial and Error in Depression Treatment?

Standard clinical practice often requires patients to wait months to determine if a Selective Serotonin Reuptake Inhibitor is effective, leading to significant emotional and financial burdens. This trial-and-error approach remains the dominant method for addressing Major Depressive Disorder, a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later